文献速递眼底病与葡萄膜炎

药物暴露作为糖尿病视网膜病变风险预测模型中的预测因素——系统综述与Meta分析

Drug Exposure As a Predictor in Diabetic Retinopathy Risk Prediction Models-A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Ophthalmol · 2024-07-19

该系统综述与Meta分析纳入28项研究、678,837例1型或2型糖尿病参与者,评估糖尿病视网膜病变(DR)风险预测模型中药物暴露的处理方式。网络Meta分析显示胰岛素与DR风险升高相关(OR=2.50,95%CI:1.61-3.86)。包含胰岛素的模型汇总C统计量为0.84(95%CI:0.80-0.88),高于含胰岛素联合其他药物组合的模型(0.79,95%CI:0.74-0.84)及不含胰岛素的模型(0.70,95%CI:0.64-0.75)。

要点

  • 药物暴露在DR预测模型中主要作为分类变量建模(23项研究)。
  • 胰岛素与DR风险升高相关(OR=2.50,95%CI:1.61-3.86)。
  • 含胰岛素的模型汇总C统计量为0.84,高于不含胰岛素的模型0.70。

核心结论

  • 药物暴露在DR预测模型中主要作为分类变量建模,胰岛素与模型性能改善相关;由于药物处理欠佳,其他药物与模型性能之间的关联可能被忽略。

研究设计与样本

  • 系统综述与Meta分析,检索EMBASE、MEDLINE和SCOPUS从建库至2023年12月,纳入28项研究、678,837例1型或2型糖尿病参与者,其中38,579例(5.7%)患有DR。

主要发现

  • 在28项研究中,19项为高偏倚风险、3项偏倚风险不明确、7项为低偏倚风险。
  • 模型中作为预测因素的药物包括:胰岛素(n=24)、抗高血压药(n=5)、口服降糖药(n=12)、降脂药(n=7)、抗血小板药(n=2)。
  • 药物暴露主要作为分类变量建模(n=23项研究),2项研究将药物暴露作为时变协变量,1项作为时间依赖协变量。
  • 胰岛素与DR风险升高相关(OR=2.50;95%CI:1.61-3.86)。
  • 包含胰岛素的模型(n=9)汇总C统计量为0.84(95%CI:0.80-0.88),高于含胰岛素联合其他药物组合的模型(n=9)的0.79(95%CI:0.74-0.84),以及不含胰岛素的模型(n=3)的0.70(95%CI:0.64-0.75)。

关键数值与推荐

  • 使用预测模型偏倚风险评估工具评价研究质量,使用GRADE评价证据确定性。
  • 胰岛素与DR风险升高相关(OR=2.50;95%CI:1.61-3.86)。
  • 包含胰岛素的模型汇总C统计量为0.84(95%CI:0.80-0.88),含胰岛素联合其他药物组合的模型为0.79(95%CI:0.74-0.84),不含胰岛素的模型为0.70(95%CI:0.64-0.75)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 局限性包括所综述研究的高偏倚风险和显著异质性。
  • 由于药物处理欠佳,其他药物与模型性能之间的关联可能被忽略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To conduct a systematic review to assess drug exposure handling in diabetic retinopathy (DR) risk prediction models, a network-meta-analysis to identify drugs associated with DR and a meta-analysis to determine which drugs contributed to enhanced model performance. DESIGN: Systematic review and meta-analysis. METHODS: We included studies presenting DR models incorporating drug exposure as a predictor. We searched EMBASE, MEDLINE, and SCOPUS from inception to December 2023. We evaluated the quality of studies using the Prediction model Risk of Bias Assessment Tool and certainty using GRADE. We conducted network meta-analysis and meta-analysis to estimate the odds ratio (OR) and pooled C-statistic, respectively, and 95% confidence intervals (CI) (PROSPERO: CRD42022349764). RESULTS: Of 5,653 records identified, we included 28 studies of 678,837 type 1 or 2 diabetes participants, of which 38,579 (5.7%) had DR. A total of 19, 3, and 7 studies were at high, unclear, and low risk of bias, respectively. Drugs included in models as predictors were: insulin (n = 24), antihypertensives (n = 5), oral antidiabetics (n = 12), lipid-lowering drugs (n = 7), antiplatelets (n = 2). Drug exposure was modelled primarily as a categorical variable (n = 23 studies). Two studies handled drug exposure as time-varying covariates, and one as a time-dependent covariate. Insulin was associated with an increased risk of DR (OR = 2.50; 95% CI: 1.61-3.86). Models that included insulin (n = 9) had a higher pooled C-statistic (C-statistic = 0.84, CI: 0.80-0.88), compared to models (n = 9) that incorporated a combination of drugs alongside insulin (C-statistic = 0.79, CI: 0.74-0.84), as well as models (n = 3) not including insulin (C-statistic = 0.70, CI: 0.64-0.75). Limitations include the high risk of bias and significant heterogeneity in reviewed studies. CONCLUSION: This is the first review assessing drug exposure handling in DR prediction models. Drug exposure was primarily modelled as a categorical variable, with insulin associated with improved model performance. However, due to suboptimal drug handling, associations between other drugs and model performance may have been overlooked. This review proposes the following for future DR prediction models: (1) evaluation of drug exposure as a variable, (2) use of time-varying methodologies, and (3) consideration of drug regimen details. Improving drug exposure handling could potentially unveil novel variables capable of significantly enhancing the predictive capability of prediction models.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bantounou MA, Nahar TAK, Plascevic J, et al. Drug Exposure As a Predictor in Diabetic Retinopathy Risk Prediction Models-A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2024. PMID: 39033831. doi:10.1016/j.ajo.2024.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。